Long-acting analogues of the naturally occurring incretin, glucagon-like peptide-1 (GLP-1)
and those modified to interact also with receptors for glucose-dependent insulinotropic …

Painful diabetic peripheral neuropathy (PDPN) is present in nearly a quarter of people with
diabetes. It is estimated to affect over 100 million people worldwide. PDPN is associated …

Background Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and
are effective disease-modifying treatments for several autoimmune diseases. Whether …

Objective This consensus statement provides (1) visual guidance in concise graphic
algorithms to assist with clinical decision-making of health care professionals in the …

При участии: Национального общества по изучению атеросклероза (НОА), Российской
ассоциации эндокринологов (РАЭ), Российского общества кардиосоматической …

Persons with diabetes and chronic kidney disease (CKD) have a high residual risk of
developing cardiovascular (CV) complications despite treatment with renin-angiotensin …

Disorders of lipid metabolism. Clinical Guidelines 2023 | Ezhov | Russian Journal of
Cardiology Russian Journal of Cardiology eng | рус User ISSN 1560-4071 (Print) ISSN …

Diabetic ketoacidosis (DKA) is a life-threatening complication, which is most common in
individuals with type 1 diabetes (T1D) and is a significant risk for morbidity and mortality, and …

Hypertension poses a significant burden in the general population, being responsible for
increasing cardiovascular morbidity and mortality, leading to adverse outcomes. Moreover …

Diabetic neuropathy is a highly prevalent complication of diabetes. It consists of a broad
range of neuropathic conditions, such as distal symmetric polyneuropathy and various forms …